These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 7671251

  • 41. T lymphocytes can be effectively recruited for ex vivo and in vivo lysis of AML blasts by a novel CD33/CD3-bispecific BiTE antibody construct.
    Aigner M, Feulner J, Schaffer S, Kischel R, Kufer P, Schneider K, Henn A, Rattel B, Friedrich M, Baeuerle PA, Mackensen A, Krause SW.
    Leukemia; 2013 Apr; 27(5):1107-15. PubMed ID: 23178753
    [Abstract] [Full Text] [Related]

  • 42. Tumor-infiltrating lymphocytes can be activated in situ by using in vivo activants plus F(ab')2 bispecific antibodies.
    Thibault C, Nelson H, Chapoval AI.
    Int J Cancer; 1996 Jul 17; 67(2):232-7. PubMed ID: 8760593
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. [Detection of placental alkaline phosphatase in ovarian cancer].
    Wang R, Song L, Ding L.
    Zhonghua Fu Chan Ke Za Zhi; 1996 Feb 17; 31(2):107-9. PubMed ID: 8758806
    [Abstract] [Full Text] [Related]

  • 48. Engineering high affinity humanized anti-p185HER2/anti-CD3 bispecific F(ab')2 for efficient lysis of p185HER2 overexpressing tumor cells.
    Zhu Z, Lewis GD, Carter P.
    Int J Cancer; 1995 Jul 28; 62(3):319-24. PubMed ID: 7628874
    [Abstract] [Full Text] [Related]

  • 49. Radiolocalisation and imaging of stably HPLAP-transfected MO4 tumours with monoclonal antibodies and fragments.
    Hendrix PG, Dauwe SE, Van De Voorde A, Nouwen EJ, Hoylaerts MF, De Broe ME.
    Br J Cancer; 1991 Dec 28; 64(6):1060-8. PubMed ID: 1764368
    [Abstract] [Full Text] [Related]

  • 50. Mutation of a single amino acid converts germ cell alkaline phosphatase to placental alkaline phosphatase.
    Watanabe T, Wada N, Kim EE, Wyckoff HW, Chou JY.
    J Biol Chem; 1991 Nov 05; 266(31):21174-8. PubMed ID: 1939159
    [Abstract] [Full Text] [Related]

  • 51. Establishment of hybridomas secreting monoclonal antibodies to placental alkaline phosphatase and development of an enzyme immunoassay for its determination.
    Kinoshita Y, Okamoto T, Mano H, Furuhashi Y, Goto S, Tomoda Y.
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Jun 05; 42(6):613-9. PubMed ID: 2205681
    [Abstract] [Full Text] [Related]

  • 52. IFNγ-induced Chemokines Are Required for CXCR3-mediated T-Cell Recruitment and Antitumor Efficacy of Anti-HER2/CD3 Bispecific Antibody.
    Li J, Ybarra R, Mak J, Herault A, De Almeida P, Arrazate A, Ziai J, Totpal K, Junttila MR, Walsh KB, Junttila TT.
    Clin Cancer Res; 2018 Dec 15; 24(24):6447-6458. PubMed ID: 29950350
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Intracerebral bispecific ligand-antibody conjugate increases survival of animals bearing endogenously arising brain tumors.
    Patrick TA, Kranz DM, Zachary JF, Roy EJ.
    Int J Cancer; 1998 Nov 09; 78(4):470-9. PubMed ID: 9797136
    [Abstract] [Full Text] [Related]

  • 58. A highly sensitive and specific chemiluminescent enzyme immunoassay for placental alkaline phosphatase in the cerebrospinal fluid of patients with intracranial germinomas.
    Watanabe S, Aihara Y, Kikuno A, Sato T, Komoda T, Kubo O, Amano K, Okada Y, Koyamaishi Y.
    Pediatr Neurosurg; 2012 Nov 09; 48(3):141-5. PubMed ID: 23429277
    [Abstract] [Full Text] [Related]

  • 59. Bispecific T cell engager (BiTE®) antibody constructs can mediate bystander tumor cell killing.
    Ross SL, Sherman M, McElroy PL, Lofgren JA, Moody G, Baeuerle PA, Coxon A, Arvedson T.
    PLoS One; 2017 Nov 09; 12(8):e0183390. PubMed ID: 28837681
    [Abstract] [Full Text] [Related]

  • 60. Bispecific antibody targeted T cell therapy of ovarian cancer: clinical results and future directions.
    Canevari S, Mezzanzanica D, Mazzoni A, Negri DR, Ramakrishna V, Bolhuis RL, Colnaghi MI, Bolis G.
    J Hematother; 1995 Oct 09; 4(5):423-7. PubMed ID: 8581379
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.